HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
CVT 2759
Also Known As:
(((5-(6-(oxolan-3-yl)amino)purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy)-N-methylcarboxamide; CVT-2759; CVT2759
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Purines: 651
CVT 2759: 1
Experts
1.
Belardinelli, L
: 1 article (01/2001)
2.
Palle, V
: 1 article (01/2001)
3.
Shryock, J C
: 1 article (01/2001)
4.
Wu, L
: 1 article (01/2001)
5.
Zablocki, J A
: 1 article (01/2001)
Related Diseases
1.
Atrioventricular Block
01/01/2001 - "
CVT-2759 did not cause second-degree AV block.
"
01/01/2001 - "
The results suggest that a weak A(1)-ADOR agonist, such as CVT-2759, may be useful to slow AV nodal conduction and thereby ventricular rate without causing AV block, bradycardia, atrial arrhythmias, or vasodilation.
"
2.
Bradycardia
01/01/2001 - "
The results suggest that a weak A(1)-ADOR agonist, such as CVT-2759, may be useful to slow AV nodal conduction and thereby ventricular rate without causing AV block, bradycardia, atrial arrhythmias, or vasodilation.
"